News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Denton Vacuum To Present Findings On Titanium Nitride Fractal Coatings

4/25/2014 7:19:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MOORESTOWN, N.J., April 25, 2014 /PRNewswire/ -- Denton Vacuum LLC, a leading manufacturer of thin film technology products, will present its findings regarding Denton's current research and development on thin film coatings for use in cardiac pacemaker leads, neural stimulation and recording electrodes May 08 at the 2014 SVC TechCon Technical Program Symposia in Chicago.

Photo -

Entitled Development of Titanium Nitride Fractal Coatings for Cardiac and Neural Electrostimulation Electrodes and presented by Craig Outten, PhD, Denton's Senior Research and Development Scientist, these findings provide further insight regarding clinically approved medical implant applications that require protective, biocompatible coatings for products such as cardiac leads and neural implants. As Dr. Outten explained, "this investigation and these findings relate thin film coatings for electrodes used in electrical stimulation of tissue, both cardiac and nerve, and the recording of electrical activity in these tissues. What we demonstrate here in our research is that we have characterized porous, columnar titanium nitride coatings deposited with repeatable, thin film processes that exhibit fractal microstructures at near room temperature." Dr. Outten's research was produced using a Denton Explorer located in Denton Vacuum's Customer Applications Development Center (CADC) as part of Denton's ongoing development work in optics and medical coatings.

Near room temperature coating processes provide the dimensional stability critical for electrodes in the application of electrical stimulation, especially for those clinically approved for neural and central nervous systems (CNS) applications, such as deep brain stimulation (DBS), in which electrodes are implanted into "deep" white matter structures in the brain to treat symptoms of Parkinson's disease and movement disorders, as well as stroke, chronic pain, major depression and chronic obesity, among others.

These findings and presentation reflect Denton Vacuum's position as a leading provider of biocompatible thin films technology for complex 3-D medical components that meet demanding clinical criteria for biocompatibility, wear, electrical impedance, uniformity and other critical properties. Denton leads the industry in providing robust, production-scale systems that answer medical implant manufacturers' unique needs.

To see this news release in its entirety, including figures and captions, visit For more information about these products, or any other products and services, feel free to contact Craig Outten, PhD, Senior Research and Development Scientist, via email or by phone at 856-380-5228.

About Denton Vacuum LLC

Now in its 50th year, Denton Vacuum continues to transform barriers into thin-film technology breakthroughs for customers across the globe. With operations in the United States and China, Denton designs and develops systems that precision-coat aerospace components, advanced optics, medical implants, solar cells, semiconductor devices and much more. Fifty years of tireless innovation have produced robust offerings ranging from high-volume production platforms to unique custom-engineered systems. Denton's technology portfolio includes thermal evaporation, e-beam evaporation, ion-beam-assisted evaporation, magnetron sputtering (including reactive sputtering), plasma-enhanced-chemical-vapor deposition (PECVD), ion etch and ion-beam-assisted deposition (IBAD). As a leading source for thin-film technology, Denton also provides value-added services and lifetime support that set new industry standards. See how barriers become breakthroughs by visiting

Read more news from Denton Vacuum LLC.

SOURCE Denton Vacuum LLC

Help employers find you! Check out all the jobs and post your resume.

Read at

comments powered by Disqus